April 17th 2025
How to maximize market-entry performance for new pharma products in an increasingly competitive launch environment.
April 15th 2025
Why a fundamental rethinking of how manufacturers engage with healthcare providers, payers, and patients is necessary in today's pharma landscape.
April 14th 2025
The Verseon CEO discusses how this advanced technology is helping to discover new drug candidates.
April 10th 2025
As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
April 9th 2025
Hyfe’s CEO discusses the importance of DTx and how it can change the way certain conditions are treated.
European Industry Takes French Regulators To Task Over Temporary Authorization
September 02, 2015.
Branded ACS Therapies to Grab Market Share from Generics, Says Report
September 2, 2015.
NHS England Survey: Staff Struggling With Severe Financial Pressure
More Than Half US Physicians Place Moderate-to-Severe Restrictions on Pharma Sales Reps
What Time is It? Time to Get a Wearable Strategy
The success of Apple's iWatch is part of the apparently unstoppable rise of wearable technology, in particular health and fitness applications, writes Peter Houston.
New Actos Trial Begins in Las Vegas
August 28, 2015.
FDA Releases Guidance on Biosimilar Naming
GSK to Divest Ofatumumab to Novartis Pharma
GSK announces plan to divest its rights in ofatumumab for auto-immune indications for up to $1 billion.
Perrigo Confident Shareholders "Will Reject Mylan's Value Destructive Transaction"
Novo Nordisk to Start Phase III Trial for Oral Biologic
August 27, 2015.
Pfizer to Divest Four Injectable Products in Hospira Acquisition
US Rep. Introduces Product Information Modernization Bill
August 26, 2015.
Mylan Responds to Perrigo's "Misleading Statements"
Researchers Move Closer to Universal Flu Vaccine
August 25, 2015.
AZ Finds New CMO
Industry Responds to FDA Metrics Program
Manufacturers seek gradual rollout of more targeted FDA quality metrics program.
Brazil’s Pharmaceutical Market Value to Approach $48 Billion by 2020
FDA Approval Hails Arrival of the 3-D Printed Drug
August 24, 2015.
Bayer UK Chief Calls for Britain to Stay in European Union
Pharma Invests in Companion Diagnostics
August 20, 2015.
Sunshine: Pushing Research Out of US?
Global Multiple Myeloma Treatment Market Value to Approach $9 Billion by 2021
Pharma Dealmaking, Venture Funding Going Strong in 2015, Says Review
FDA Approval for "Female Viagra"
August 18, 2015.
Google-Backed Healthcare Firm Closes $17.5m Funding Round
August 19, 2015.
Rx-360 Releases Business Plan, Seeks CEO
Analysis Points to Downward Trend in US Clinical Research Spending
US Dept of Justice to Arraign PharmacyChecker Exec on Counterfeit and Mislabeled Drugs Charges
FDA Guidance on Botanical Drugs
UK Drug Watchdog Gets Tough on Antibiotics and "Soft Touch" Doctors